Cognitant Group and UCB have introduced a new programme that provides health information in the form of visual and immersive experiences.This new technology will be user tested in Addenbrooke’s Hospital (Cambridge, UK), available to patients being prescribed a medicine to treat arthritis. This will help patients to understand all aspects of their consultation, and in turn, better self-manage their disease. Developed in partnership with Cambridge Arthritis Research Endeavour (CARE), the programme is supported by an educational grant from UCB.
UCB is a global biopharma company, committed to supporting people living with severe diseases in immunology and neurology. The support for Cognitant Group will further enhance patient care at Addenbrooke’s Hospital
In the treatment of rheumatoid arthritis, a medicine can be used to interrupt the immune system signals involved in the damage of joint tissue. The immersive patient programme entails virtual consultations with a consultant rheumatologist and nurse. Patients will have access to an interactive explanation of the disease process, and the mode of action of the medicine used to treat it. It will also feature a 360-degree video of an injection demo, and a series of infographics and virtual objects to aid knowledge retention.
The programme is intended to improve compliance with medication and ensure better outcomes for the patients by prescribing interactive health information. Under the new system, the doctor will prescribe information to patients using the healthinote app, a platform that provides immersive experiences across a range of chronic diseases, the Cognitant Group website or a printed code. The patient will then be able to access the content using a simple QR code or link.
Tim Ringrose, CEO of Cognitant Group says, “Working with doctors, healthcare professionals and patients, we aim to ensure that all patients have access to the most comprehensive and personalised health information. By transporting people into a virtual world, complex information can be visualised and explained as clearly as possible. To have received backing from this leading biopharma company reflects their confidence in our proposition to empower patients to take control of their health.”
Paul Atherfold, Medical Solutions Lead for Immunology, UK and Ireland at UCB said: “This programme provides an exciting opportunity to support patients living with chronic diseases to better understand their condition, and have control over their health and treatment.”
Dr Deepak Jadon, Consultant Rheumatologist at Addenbrooke’s Hospital says, “There has long been a major unmet need in terms of patients having access to reliable, doctor-vetted, comprehensive and free medical education material. We hope that this immersive education pilot will improve patient satisfaction with our clinical service, compliance with their medication and safe utilisation of these highly-effective but immunosuppressant medications.”
For more news on virtual reality click here >